You are viewing the site in preview mode
Skip to main content
| |
Bridging group
|
Control group
|
p value1
|
|---|
|
Thromboembolic events [n, %]
| |
2 (0.8%)
|
5 (1.9%)
|
0.45
|
|
Postoperative bleeding2
|
Major [n, %]
|
22 (8.4%)
|
2 (0.8%)
|
< 0.0001
|
|
Minor [n, %]
|
36 (13.7%)
|
14 (5.3%)
|
0.001
|
|
Red blood cell transfusion [n, %]
| |
23 (8.7%)
|
2 (0.8%)
|
< 0.0001
|
|
Reoperation [n, %]
| |
40 (15.2%)
|
14 (5.4%)
|
< 0.0001
|
|
Classification of complications3
|
Grade IIIa–V [n, %]
|
61 (23.2%)
|
33 (12.5%)
|
0.001
|
|
Grade IVa–V [n, %]
|
18 (6.8%)
|
8 (3%)
|
0.044
|
|
In-hospital mortality [n, %]
| |
4 (1.5%)
|
5 (1.9%)
|
1.0
|
|
Intermediate care/intensive care [n, %]
| |
118 (44.9%)
|
74 (28.1%)
|
< 0.0001
|
|
Length of stay [days]
| |
12 ± 11
|
9 ± 9
|
0.009
|
- 1p values of continuous outcomes were calculated by a two-sided two-sample t test assuming equal variances; p values of categorical outcomes were calculated by a two-sided χ2 test or, in case of categories with less than 5 subjects, by Fisher’s exact test
- 2According to the International Society on Thrombosis and Haemostasis (Schulman et al. 2010)
- 3According to Clavien-Dindo (Dindo et al. 2004)
